Literature DB >> 30046321

Production of MPT-64 recombinant protein from virulent strain of Mycobacterium bovis.

M Mohammadi Tashakkori1, M Tabatabaei2, M Tebianian3, N Mosavari3.   

Abstract

Tuberculosis (TB) is a zoonotic infectious disease common to humans and animals which has been caused by a rod shaped, acid fast bacterium, called Mycobacterium bovis. The rapid and sensitive detection is a great challenge for TB diagnosis. The virulent strains of Mycobacterium tuberculosis complex (MTBC) have 16 different regions of difference (RD) in their genome which encode some important antigens. The major protein of M. bovis 64 (MPT-64) is one of the main immune-stimulating antigens which are encode by RD-2 region. The aim of the present study was cloning, expression and purification of MPT-64 as a protein antigen of M. bovis in a prokaryotic system for the usage in the future diagnostic studies. In this experimental study, the mpt-64 gene with 687 bp has been proliferated from M. bovis whole genome by polymerase chain reaction (PCR) method. The PCR product has been digested by BamHI and HindIII restriction enzymes and cloned into pQE-30 plasmid. The recombinant protein has been expressed in the Escherichia coli M15 with induction by isopropyl-β-D-thiogalactopyranoside (IPTG). The expressed protein was analyzed on SDS-PAGE, and purified with Nitrilotriacetic acid (Ni-NTA) column. Finally, its biological properties were confirmed in Western blotting method using specific antibodies. Data showed the successful cloning of mpt-64 gene (as a 687 bp segment) in expression vector. The MPT-64 recombinant protein was ideally expressed and purified as a 24 kDa protein. The result of this study indicated that MPT-64 recombinant protein (24 kDa) has been successfully expressed and purified in a prokaryotic system, so this protein could be used for differential diagnosis of pathogenic and non-pathogenic Mycobacterium, in suspected BTB cases.

Entities:  

Keywords:  Cloning; MPT-64 protein; Mycobacterium bovis; Recombinant protein

Year:  2018        PMID: 30046321      PMCID: PMC6056143     

Source DB:  PubMed          Journal:  Iran J Vet Res        ISSN: 2252-0589            Impact factor:   1.376


  20 in total

Review 1.  Heat-shock proteins: immunity and autoimmunity.

Authors:  D B Young
Journal:  Curr Opin Immunol       Date:  1992-08       Impact factor: 7.486

2.  Fluorescence polarization assay for the detection of antibodies to Mycobacterium bovis in bovine sera.

Authors:  Michael E Jolley; Mohammad S Nasir; Om P Surujballi; Anna Romanowska; Tomas B Renteria; Alfonso De la Mora; Ailam Lim; Steven R Bolin; Anita L Michel; Miladin Kostovic; Edward C Corrigan
Journal:  Vet Microbiol       Date:  2006-10-25       Impact factor: 3.293

3.  An improved whole-blood gamma interferon assay based on the CFP21-MPT64 fusion protein.

Authors:  Ruiling Fu; Chun Wang; Chunwei Shi; Mengji Lu; Zhengming Fang; Jia Lu; Fang Wang; Xionglin Fan
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

4.  Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

Authors:  C Dye; G P Garnett; K Sleeman; B G Williams
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

5.  Restriction fragment length polymorphism typing of mycobacteria.

Authors:  D van Soolingen; P E de Haas; K Kremer
Journal:  Methods Mol Med       Date:  2001

Review 6.  Mycobacterial antigens: a review of their isolation, chemistry, and immunological properties.

Authors:  T M Daniel; B W Janicki
Journal:  Microbiol Rev       Date:  1978-03

7.  An update on bovine tuberculosis programmes in Latin American and Caribbean countries.

Authors:  Isabel N de Kantor; Viviana Ritacco
Journal:  Vet Microbiol       Date:  2005-11-28       Impact factor: 3.293

8.  [Recent progress in mycobacteriology].

Authors:  Masaji Okada; Kazuo Kobayashi
Journal:  Kekkaku       Date:  2007-10

Review 9.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 10.  Current issues on molecular and immunological diagnosis of tuberculosis.

Authors:  Sang-Nae Cho
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

View more
  1 in total

1.  Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme.

Authors:  Lorenzo Turcano; Theo Battista; Esther Torrente De Haro; Antonino Missineo; Cristina Alli; Giacomo Paonessa; Gianni Colotti; Steven Harper; Annarita Fiorillo; Andrea Ilari; Alberto Bresciani
Journal:  PLoS Negl Trop Dis       Date:  2020-05-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.